Clinical Trial Update: Aliskiren for Immunoglobulin A (IgA) Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial of aliskiren for IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: IgA Nephropathy | Phase 3 | Status: COMPLETED